Huge potential in this biotech stockThis stock is high risk but carries a lot of potential. The structure is a textbook play.
DTIL trade ideas
DTIL Long ideaDTIL is now trading above its supporting moving averages. The MACD is trending higher and Volume is coming up. the 200 sma looms above as resistance but I like this one.
DTIL - DAILY CHARTHi, today we are going to talk about Precision BioSciences and its current landscape.
Precision BioSciences, the genome editing company has received attention lately as the Cancer - Drug Race heats up, in the middle a day of the announcements of a $5.2 billion total in Acquisitions by big names of the pharmaceuticals sector, such as Merck & Co. and Sanofi, that had made strategic movements on the oncology sector. Precision BioSciences has been crushed, after unveiled early-stage CAR T data in NHL, the data puts the company behind of competition, as the sector becomes more and more competitive.
Thank you for reading and leave your comments if you like.
To have access to our exclusive contents, join the Traders Heaven today! Link Below.
Disclaimer: All content of Golden Dragon has only educational and informational purposes, and never should be used or take it as financial advice.
Precision Biosciences " Massive V Bottom Breakout " Precision Biosciences is a cancer and genetic therapeutic company,
based in North Carolina that went public this past March at 18.00 a share.
The "3 Box Technical Indicator" shown here, shows DTIL
has made a Very Powerful " V Bottom Breakout" this past week.
When you purchase a stock,always look for "over performance",as a key criteria to ownership.
Precision Biosciences technically now has a 3 Box Upside Target of $30.00 a share.
It closed today at 19.66, with over 1 million shares traded.
THE_UNWIND
12/6/19
NEW YORK
$DTIL Precision Biosciences Inc gets $24 target 90% upsideWhen a stock gets this much Analysts attention in the one day we take notice. With the average price target of $24 this has huge upside potential. It is a name that requires much more research but we are very interested by these upgrades.
